ScreenerHero
PHRPhreesia, Inc.
NYSE · US · Healthcare · Health Information Services · phreesia.com
11.89USD-0.63%Mkt Cap: 738.82M $P/E: 74.75

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. It offers solutions including appointment optimization and referral management u…

Industry Peers

Health Information Services
Screen all
VEE
Veeva System Inc. R
$38.07BUSDP/E 44.2
VEEV
Veeva Systems Inc Class A
$40.77BUSDP/E 44.6
BTSG
BrightSpring Health Services Inc. Common Stock
$11.74BUSDP/E 53.0
TEM
Tempus AI Inc. Class A Common Stock
$11.05BUSD
HQY
HealthEquity, Inc.
$8.71BUSDP/E 38.9
TXG
10x Genomics, Inc.
$8.10BUSD
HNGE
Hinge Health Inc. Class A Common Stock
$7.14BUSDP/E 10.8
WAY
Waystar Holding Corp. Common Stock
$4.76BUSDP/E 35.5
DOCS
Doximity, Inc.
$4.62BUSDP/E 30.9
HTFL
Heartflow Inc. Common Stock
$3.96BUSD
PRVA
Privia Health Group, Inc.
$2.75BUSDP/E 97.7
OMCL
Omnicell, Inc.
$1.66BUSDP/E 43.4
OMDA
Omada Health Inc. Common Stock
$1.50BUSDP/E 36.5
SDGR
Schrödinger, Inc.
$1.48BUSD
CERT
Certara, Inc.
$1.28BUSD
GDRX
GoodRx Holdings, Inc.
$1.21BUSDP/E 59.0
TDOC
Teladoc Health, Inc.
$1.18BUSD
TALK
Talkspace Inc. Common Stock
$870.57MUSD
HSTM
HealthStream, Inc.
$834.80MUSDP/E 39.7
EQS
Equasens Société anonyme
$559.62MUSDP/E 13.2
HeadlineSourceTime
Older
NRx Pharmaceuticals, Inc. (NRXP) Reports Q2 Loss, Misses Revenue Estimates

NRx Pharmaceuticals (NRXP) delivered earnings and revenue surprises of -100.00% and -54.13%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Zacks
ADC Therapeutics SA (ADCT) Reports Q2 Loss, Lags Revenue Estimates

ADC Therapeutics (ADCT) delivered earnings and revenue surprises of +42.11% and -4.48%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Zacks
Enovis (ENOV) Beats Q2 Earnings and Revenue Estimates

Enovis (ENOV) delivered earnings and revenue surprises of +8.43% and +0.15%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Zacks
Schrodinger, Inc. (SDGR) Q2 Earnings and Revenues Top Estimates

Schrodinger (SDGR) delivered earnings and revenue surprises of +113.33% and +15.58%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Zacks
Should Value Investors Buy Phreesia (PHR) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks
Phreesia (PHR) Stock Fair Value Edges Lower As Analysts Split On Growth Outlook
Simply Wall St.
Phreesia's (NYSE:PHR) Strong Earnings Are Of Good Quality
Simply Wall St.
Are Investors Undervaluing Phreesia (PHR) Right Now?
Zacks
Do You Believe in Phreesia’s (PHR) Strong Upside Potential?
IInsider Monkey
Phreesia Inc (PHR) Q1 2027 Earnings Call Highlights: Strong Revenue Growth and Positive Net ...
GuruFocus.com
Phreesia, Inc. Q1 2027 Earnings Call Summary
Moby
Phreesia (PHR) Q1 2027 Earnings Transcript
Motley Fool
Phreesia Q1 Earnings Call Highlights
MarketBeat
Compared to Estimates, Phreesia (PHR) Q1 Earnings: A Look at Key Metrics
Zacks
Phreesia (PHR) Q1 Earnings and Revenues Beat Estimates
Zacks
Seeking Clues to Phreesia (PHR) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics
Zacks
Why Phreesia Stock Got Clocked Today
Motley Fool
Here Are Wednesday’s Top Wall Street Analyst Research Calls: BJ’s Wholesale Club, Centene, Cigna, Crown Castle, ETSY, Franco-Nevada, Humana, Ovintiv, X-Energy, and More
24/7 Wall St.
How The Phreesia (PHR) Narrative Is Shifting With Slower Ad Growth And Tougher Competition
Simply Wall St.